1. Home
  2. BUDA vs FBIO Comparison

BUDA vs FBIO Comparison

Compare BUDA & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BUDA

Buda Juice Inc. Common Stock

N/A

Current Price

$10.79

Market Cap

91.7M

ML Signal

N/A

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$3.28

Market Cap

101.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUDA
FBIO
Founded
2013
2006
Country
United States
United States
Employees
39
78
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.7M
101.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BUDA
FBIO
Price
$10.79
$3.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$17.00
AVG Volume (30 Days)
20.9K
541.4K
Earning Date
03-26-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$55.22
Revenue Next Year
N/A
$40.55
P/E Ratio
$24.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$1.77
52 Week High
$12.00
$4.53

Technical Indicators

Market Signals
Indicator
BUDA
FBIO
Relative Strength Index (RSI) 63.66 63.63
Support Level $8.21 $3.28
Resistance Level N/A $3.35
Average True Range (ATR) 0.82 0.21
MACD 0.26 0.01
Stochastic Oscillator 64.00 90.77

Price Performance

Historical Comparison
BUDA
FBIO

About BUDA Buda Juice Inc. Common Stock

Buda Juice Inc operates in a beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never heat-treated, pasteurized, never HPP- processed, never UV- treated and always cold.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Share on Social Networks: